Unknown

Dataset Information

0

Phase II trial melphalan ILI plus ADH-1 for treatment of in-transit extremity melanoma


ABSTRACT: An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with ADH-1 followed by melphalan in the setting of isolated limb infusion Gene expression profiles were obtained from 28 lesions across 15 patients and evaluated for expression values that correlated with ADH-1 treatment given 4-8hrs prior to melphalan isolated limb infusion Chemotherapy response analysis: complete response - CR; partial response - PR; stable disease - SD; progressive disease - PD; lost to follow-up - LTU/F ADH-1 treatment classification: 'pre' - lesions obtained prior to any treatment with ADH-1; 'post' - lesions obtained just prior to ILI with melphalan after 1 treatment with ADH-1; '2nd' - lesions obtained after a 2nd dose of ADH-1 given 8 days after melphalan ILI

ORGANISM(S): Homo sapiens

SUBMITTER: Augustine Christina 

PROVIDER: S-ECPF-GEOD-22968 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

2011-01-01 | GSE22968 | GEO
2011-01-01 | E-GEOD-22968 | biostudies-arrayexpress
| S-EPMC4668281 | biostudies-literature
2010-02-26 | GSE19293 | GEO
| S-ECPF-GEOD-8615 | biostudies-other
2008-11-07 | E-GEOD-8615 | biostudies-arrayexpress
2010-03-09 | E-GEOD-19293 | biostudies-arrayexpress
2011-12-22 | E-GEOD-34599 | biostudies-arrayexpress
2008-10-30 | GSE10282 | GEO
2011-12-22 | GSE34599 | GEO